Anti-relapse medications: Preclinical models for drug addiction treatment
Open accessThe DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
Addiction is a chronic relapsing brain disease and treatment of relapse to drug-seeking is considered the most challenging part of treating addictive disorders. Relapse can be modeled in laboratory animals using reinstatement paradigms, whereby behavioral responding for a drug is extinguished and then reinstated by different trigger factors, such as environmental cues or stress. In this review, we first describe currently used animal models of relapse, different relapse triggering factors, and the validity of this model to assess relapse in humans. We further summarize the growing body of pharmacological interventions that have shown some promise in treating relapse to psychostimulant addiction. Moreover, we present an overview on the drugs tested in cocaine or methamphetamine addicts and examine the overlap of existing preclinical and clinical data. Finally, based on recent advances in our understanding of the neurobiology of relapse and published preclinical data, we highlight the most promising areas for future anti-relapse medication development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Drug Addiction, Dysregulation of Reward, and Allostasis
Koob, G. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00195-0 · Cited by 2,953
The Neural Basis of Addiction: A Pathology of Motivation and Choice
Kalivas, P. W., & Volkow, N. D. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.8.1403 · Cited by 2,757
Meta‐analysis of cue‐reactivity in addiction research
Carter, B. L., & Tiffany, S. T. (1999) · Addiction · doi:10.1046/j.1360-0443.1999.9433273.x · Cited by 1,638 · cited 1×
“…laboratory animals (See, 2002; Shaham et al., 2003; Stewart et al., 2000; Weiss, 2005) can be triggered by conditions reported to provoke drug craving and relapse in human such as a drug (de Wit, 1996), drug-associated cues (Carter & Tiffany, 1999; Childress et al., 1993), or stress (Sinha, 2001).”
BackgroundThe reinstatement model of drug relapse: history, methodology and major findings
Shaham, Y., Shalev, U., Lu, L., de Wit, H., & Stewart, J. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1224-x · Cited by 1,615
How does stress increase risk of drug abuse and relapse?
Sinha, R. (2001) · Psychopharmacology · doi:10.1007/s002130100917 · Cited by 1,505 · cited 1×
“…laboratory animals (See, 2002; Shaham et al., 2003; Stewart et al., 2000; Weiss, 2005) can be triggered by conditions reported to provoke drug craving and relapse in human such as a drug (de Wit, 1996), drug-associated cues (Carter & Tiffany, 1999; Childress et al., 1993), or stress (Sinha, 2001).”
BackgroundTzschentke, T. M. (2007) · Addiction Biology · doi:10.1111/j.1369-1600.2007.00070.x · Cited by 1,336
Evidence for Addiction-like Behavior in the Rat
Deroche-Gamonet, V., Belin, D., & Piazza, P. V. (2004) · Science · doi:10.1126/science.1099020 · Cited by 1,135 · cited 1×
“Animals readily self-administer most drugs used by humans and show patterns of drug intake that mimic patterns seen in human users (Caine & Koob, 1993; Collins et al., 1984; Deroche-Gamonet et al., 2004).”
BackgroundReinstatement of cocaine-reinforced responding in the rat
de Wit, H., & Stewart, J. (1981) · Psychopharmacology · doi:10.1007/bf00432175 · Cited by 928 · cited 1×
“Drug-induced relapse—Drug priming injection has been known for over three decades to be a potent stimulus to renew extinguished responding of drug-seeking (de Wit & Stewart, 1981; Gerber & Stretch, 1975).”
BackgroundThe circuitry mediating cocaine-induced reinstatement of drug-seeking behavior
McFarland, K., & Kalivas, P. W. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-21-08655.2001 · Cited by 905
Neurobiology of relapse to heroin and cocaine seeking: a review
Shalev, U., Grimm, J. W., & Shaham, Y. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.1.1 · Cited by 880 · cited 1×
“Reinstatement of drug-seeking has been studied using different variations of the reinstatement model (Shalev et al., 2002): between-session, within-session and betweenwithin-session.”
MethodVolkow, N. D., Fowler, J. S., & Wang, G.-J. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.07.019 · Cited by 616
Sinha, R., Garcia, M., Paliwal, P., Kreek, M. J., & Rounsaville, B. J. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.3.324 · Cited by 528 · cited 1×
“Moreover, stressful events and exposure to environmental cues associated with drug-taking behavior are known triggering factors to relapse in humans (Foltin & Haney, 2000; Shiffman, 1982; Sinha et al., 2006).”
BackgroundRole for hypocretin in mediating stress-induced reinstatement of cocaine-seeking behavior
Boutrel, B., Kenny, P. J., Specio, S. E., Martin-Fardon, R., Markou, A., Koob, G. F., & de Lecea, L. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507480102 · Cited by 520
Myths about the treatment of addiction
O'Brien, C., & Thomas McLellan, A. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90409-2 · Cited by 512
The neurocircuitry of addiction: an overview
Feltenstein, M. W., & See, R. E. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.51 · Cited by 421 · cited 1×
“…and NAc shell (stress reinstatement) converge on motor pathways involving glutamatergic projection from the dmPFC to NAc core that represents a ‘final common pathway’ for all three types of instigating factors in relapse (Feltenstein & See, 2008; Kalivas & McFarland, 2003; Shaham et al., 2003).”
BackgroundSelf-citationNeurobiology of craving, conditioned reward and relapse
Weiss, F. (2005) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2004.11.001 · Cited by 411 · cited 2×
“…of the reinstatement model is supported by evidence that reinstatement in laboratory animals (See, 2002; Shaham et al., 2003; Stewart et al., 2000; Weiss, 2005) can be triggered by conditions reported to provoke drug craving and relapse in human such as a drug (de Wit, 1996), drug-associated cues…”
BackgroundA Double-Blind, Placebo-Controlled Trial of Modafinil for Cocaine Dependence
Dackis, C. A., Kampman, K. M., Lynch, K. G., Pettinati, H. M., & O'Brien, C. P. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300600 · Cited by 391 · cited 6×
“Modafinil 62 Cocaine dependent ↑ negative urine screen (Dackis et al., 2005)”
BackgroundInfluentialFuchs, R. A., Branham, R. K., & See, R. E. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.5146-05.2006 · Cited by 298
Self-citationAlpha-2 Adrenergic Receptor Agonists Block Stress-Induced Reinstatement of Cocaine Seeking
Erb, S. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00158-x · Cited by 270 · cited 6×
“Thus, stress-induced reinstatement of drug-seeking behavior has been used to model this human situation (Erb et al., 1996; Koob & Le Moal, 2001; Shaham, Erb et al., 2000).”
MethodInfluentialDopamine D3Receptor Antagonism Inhibits Cocaine-Seeking and Cocaine-Enhanced Brain Reward in Rats
Vorel, S. R., Ashby, C. R., Paul, M., Liu, X., Hayes, R., Hagan, J. J., Middlemiss, D. N., Stemp, G., & Gardner, E. L. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-21-09595.2002 · Cited by 269 · cited 1×
“…3 mg/kg, i.p. ↑ cue (Cervo et al., 2003) SB-277011-A (selective D3 antagonist) 5-30 mg/kg, i.p.or p.o. ↓ cue (Cervo et al., 2007; Gilbert et al., 2005; Gal & Gyertyan, 2006) 3-24 mg/kg i.p. ↓ cocaine (Vorel et al., 2002; Xi et al., 2005) 3-12 mg/kg, ip ↓ stress (footshock) (Xi et al., 2004) NGB…”
Shiffman, S., Hickcox, M., Paty, J. A., Gnys, M., Kassel, J. D., & Richards, T. J. (1996) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.64.5.993 · Cited by 254
Modafinil for the treatment of cocaine dependence
Anderson, A. L., Reid, M. S., Li, S.-H., Holmes, T., Shemanski, L., Slee, A., Smith, E. V., Kahn, R., Chiang, N., Vocci, F., et al. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2009.04.015 · Cited by 235
Bupropion for the treatment of methamphetamine dependence
Elkashef, A. M., Rawson, R. A., Anderson, A. L., Li, S.-H., Holmes, T., Smith, E. V., Chiang, N., Kahn, R., Vocci, F., Ling, W., et al. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301481 · Cited by 234 · cited 3×
“Drug # patients Specific diagnoses Result Reference Propranolol 108 Cocaine dependent with severe withdrawal ↑ duration of abstinence, ↓ withdrawal symptoms (Kampman et al., 2001) 199 (Kampman et al., 2006) Modafinil 62 Cocaine dependent ↑ negative urine screen (Dackis et al., 2005) Topiramate 40 Cocaine dependent ↑ r…”
BackgroundMethodNeural substrates of cocaine-cue associations that trigger relapse
See, R. E. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.09.034 · Cited by 228 · cited 1×
“A series of projections, primarily involving DA and Glu, from the VTA, basolateral amygdala (BLA), dmPFC, and NAc core, appear to be the primary pathways mediating conditioned-cued reinstatement (See, 2005).”
BackgroundSelf-citationStreeton, C. (2001) · Alcohol and Alcoholism · doi:10.1093/alcalc/36.6.544 · Cited by 228 · cited 1×
“As already mentioned, naltrexone has been shown to block reinstatement of alcohol-seeking in rats (Le et al., 1999; Volpicelli, 1995) and also prevent relapse in alcoholics (Latt et al., 2002; Streeton & Whelan, 2001).”
BackgroundZhou, W., & Kalivas, P. W. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.06.008 · Cited by 225
Repeated N-Acetylcysteine Administration Alters Plasticity-Dependent Effects of Cocaine
Madayag, A., Lobner, D., Kau, K. S., Mantsch, J. R., Abdulhameed, O., Hearing, M., Grier, M. D., & Baker, D. A. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2808-07.2007 · Cited by 225 · cited 1×
“…cystine-glutamate exchange) 100 mg/kg, i.p. 60 mg/kg, s.c. 60 mg/kg, i.p. (daily in self-administration) ↓ cocaine (Baker et al., 2003a,b) (Moran et al., 2005) (Madayag et al., 2007) Acamprosate 300 mg/kg, i.p. ↓ cocaine, ↓ cue (Bowers et al., 2007) GABA Baclofen (GABAB agonist) 1.25 or…”
InfluentialLevin, F. R., Evans, S. M., Brooks, D. J., & Garawi, F. (2007) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2006.07.004 · Cited by 220 · cited 1×
“Methylphenidate showed some beneficial effects in reducing cocaine use only in cocaine dependent patients with comorbid attention deficit hyperactivity disorder (Levin et al., 2007).”
BackgroundShaham, Y., Highfield, D., Delfs, J., Leung, S., & Stewart, J. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00899.x · Cited by 201
A double-blind, placebo-controlled trial of modafinil for cocaine dependence
Dackis, C. A., Kampman, K. M., Lynch, K. G., Plebani, J. G., Pettinati, H. M., Sparkman, T., & O'Brien, C. P. (2012) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2011.12.014 · Cited by 187
Grabowski, J., Rhoades, H., Stotts, A., Cowan, K., Kopecky, C., Dougherty, A., Moeller, F. G., Hassan, S., & Schmitz, J. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300392 · Cited by 185 · cited 3×
“In addition, dextroamphetamine treatment decreased cocaine use in cocaine- or cocaine/heroin-dependent subjects (Grabowski et al., 2004; Shearer et al., 2003).”
BackgroundA multicenter trial of bupropion for cocaine dependence in methadone-maintained patients
Margolin, A., Kosten, T. R., Avants, S. K., Wilkins, J., Ling, W., Beckson, M., Arndt, I. O., Cornish, J., Ascher, J. A., Li, S.-H., et al. (1995) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(95)01198-6 · Cited by 168
Levodopa pharmacotherapy for cocaine dependence: choosing the optimal behavioral therapy platform
Schmitz, J. M., Mooney, M. E., Moeller, F. G., Stotts, A. L., Green, C., & Grabowski, J. (2008) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2007.11.004 · Cited by 124
Highfield, D. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00227-5 · Cited by 81
Leri, F., Tremblay, A., Sorge, R. E., & Stewart, J. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300435 · Cited by 80 · cited 3×
“Moreover, rats maintained chronically on methadone (Leri et al., 2004) or buprenorphine (Sorge et al., 2005) showed reductions in both heroin- and cocaine-induced reinstatement of drug-seeking.”
BackgroundInfluentialOrson, F. M., Kinsey, B. M., Singh, R. A. K., Wu, Y., Gardner, T., & Kosten, T. R. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1441.027 · Cited by 79 · cited 3×
“Moreover, early preclinical studies of methamphetamine are underway and have demonstrated various effects on methamphetamine self-administration in rats (Duryee et al., 2009; McMillan et al., 2004; Orson et al., 2008).”
BackgroundSpiller, K., Xi, Z.-X., Li, X., Ashby, C. R., Callahan, P. M., Tehim, A., & Gardner, E. L. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.04.006 · Cited by 58
Cited by
Baskerville, T. A., & Douglas, A. J. (2010) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00154.x · Cited by 377
Animal models of psychiatric disorders
(2012) · Handbook of Clinical Neurology · doi:10.1016/b978-0-444-52002-9.00009-7 · Cited by 336
Everitt, B. J. (2014) · European Journal of Neuroscience · doi:10.1111/ejn.12644 · Cited by 318
Kelamangalath, L., & Wagner, J. J. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.06.006 · Cited by 25
“Extinction in the absence of cues is often employed in selfadministration studies of reinstatement of drug-seeking behavior (Yahyavi-Firouz-Abadi and See, 2009), and we have previously observed a reduction of CS-induced reinstatement in ShA rats (Kelamangalath et al., 2007).”
Background
Metadata
- Authors
- Yahyavi-Firouz-Abadi, N., & See, R. E.
- Venue
- Pharmacology & Therapeutics
- Publisher
- Elsevier BV
- Published
- 2009-11
- Volume
- 124
- Issue
- 2
- Pages
- 235-247
- ISSN
- 0163-7258 (ISSN-L)
- OpenAlex
- W1974504536
- Cited by
- 70
- References
- 37
- FWCI
- 3.51
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.